THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;GLG PHARMA, LLC;MRIGLOBAL
发明人:
SHOEMAKER, Robert H.,WHITE, Jonathan M.,GUPTA, Shanker,LOVELL, Michael W.
申请号：
PE2019001997
公开号：
PE20200611A1
申请日:
2018.04.05
申请国别(地区):
PE
年份:
2020
代理人:
摘要：
It refers to 2-hydroxy-4 - [[2 - [(4-methylphenyl) sulfuric acid] acetyl] amino] and 2-amino-2 - (hydroxy) 1,3-acetone, which can be dissolved in water and remain stable for a long time. This salt is a STAT3 inhibitor. It also refers to the synthesis of a drug, including its usefulness in the treatment or prevention of breast cancer.Referido a una sal de acido benzoico 2-hidroxi-4-[[2-[[(4-metilfenil)sulfonil]oxi]acetil]amino] y 2-amino-2-(hidroximetil)-1,3-propanediol, la cual es soluble en agua y estable por periodos de tiempo prolongados. Dicha sal es un inhibidor de STAT3. Tambien se refiere a una composicion farmaceutica que la comprende siendo util en el tratamiento o prevencion del cancer de mama.
